Access brought to you by: LOCKSS

Cardiology Clinical Trials

First-in-Man Results Show That a Leadless Catheter Pacemaker is Feasible, Safe, and Effective
Reablation Superior to Antiarrhythmic Drug Therapy after a Failed Ablation Procedure
Improving Clinician Adherence to Evidence-Based Recommendations Reduces Unnecessary ICD Shocks
Driver Mapping and Driver-Guided Ablation Reduces Need for Antiarrhythmic Medication
MASS COM Trial: Nonemergency PCI Safe without on-Site Surgery Capability
ASTRONAUT Study: Aliskiren Does Not Improve Postdischarge Outcomes in Patients Hospitalized for Chronic Heart Failure
A Comparison of Clinical Outcomes following on-versus off-CABG Shows Mixed Results
HPS2-THRIVE: Niacin Fails to Show Benefit in Patients at High Risk of Vascular Events
High-Dose Rosuvastatin Reduces Contrast-Induced Nephropathy
The TACT Trial: Provocative Results for High-Dose Vitamins and Chelation Therapy

Pages